Hawaii is using some of its CARES Act money to create a version of the Civilian Conservation Corps. The state is now trying to spend the last of the funds before the deadline later this month.
The Kansas City Star apologized for failing generations of Black people over its 140-year history. NPR's Mary Louise Kelly talks with Star reporter Mara Rose Williams and editor Mike Fannin.
More women are coming forward to say they were pressured to have reproductive surgeries they did not want or understand, offering a glimpse into alleged medical abuses at an ICE detention center.
Oil and gas companies make enough pellets each year to fill a stadium several times over. The oil industry has long known it has a pellet pollution problem, but that's not what it told the public.
Lilli Rayne's dog-walking business was taking off and she was finally preparing to buy a house. Then the pandemic struck. She's among the millions of Americans struggling to stay afloat right now.
President Trump upset the architectural world in February when he proposed an executive order mandating traditional, classical architecture for new federal buildings. That order is now a reality.
A CDC panel recommends that people over 75 and front-line essential workers should be prioritized as the next group to be vaccinated against the coronavirus.
Despite some early bumps, the arrival of the first shipments of a COVID-19 vaccine was celebrated this past week by those who've been caring for patients since the early days of the pandemic.
The Taliban have waged attacks across the country, prompting a call to reduce the violence from Gen. Mark Milley. In Kabul, the public worries about the Taliban's return.
McCartney has been busy in quarantine. The artist speaks about his new album, McCartney III, the quirks of writing love songs and remembering his late friends John Lennon and George Harrison.
Scientists and investors born outside the U.S. played crucial roles in the development of COVID-19 vaccines — a remarkable vindication for the argument that innovation depends on immigration.
Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.